Science & Enterprise subscription

Follow us on Twitter

  • Voice telephone, who knew? ... Why the Phone Is Key to Getting Covid Shots in Arms https://t.co/zf0KWGX7Ca
    about 16 mins ago
  • Israel is emerging as the world's leader in vaccinating its population, and seeing results in declines of new Covid… https://t.co/FBswRzZQld
    about 4 hours ago
  • New post on Science and Enterprise: Infographic – Israel Halts Covid-19 Spread with Vaccines https://t.co/ezP927woim #Science #Business
    about 4 hours ago
  • We wrote about this project last July. Read about it first on Science & Enterprise. ... Researchers Are Hatching a… https://t.co/rujRcnlZax
    about 8 hours ago
  • A biotechnology company using protein dynamics to develop precision cancer therapies is acquiring a drug discovery… https://t.co/AzEb3ERy5f
    about 23 hours ago

Please share Science & Enterprise

Intensive Care Bed Designed for Preterm Babies

Clinical trial results show a hospital bed that simulates contact with a mothers’ body helps preterm babies cope with unpleasant medical procedures. . . . → Read More: Intensive Care Bed Designed for Preterm Babies

Clinical Trial Tests In-Tumor Breast Cancer Therapy

Breast cancer self exam

A clinical trial is set to begin that tests a treatment for early-stage breast cancer delivered directly into the tumor before surgery is scheduled. . . . → Read More: Clinical Trial Tests In-Tumor Breast Cancer Therapy

Fast, Inexpensive Covid-19 Immunity Test Devised

Drop of blood

Researchers in Canada developed a simple and inexpensive test for Covid-19 antibodies requiring a pinprick of blood, and returning results in under an hour. . . . → Read More: Fast, Inexpensive Covid-19 Immunity Test Devised

CEPI Funding SARS-CoV-2 Variant Vaccines

SARS-Cov-2 virus

CEPI, an international consortium, is funding development of vaccines to protect against SARS-CoV-2 mutations, starting with B.1.351 discovered in Brazil. . . . → Read More: CEPI Funding SARS-CoV-2 Variant Vaccines

Trial Testing Multi-Company Covid-19 Therapy

SARS-Cov-2 virus

A clinical trial already underway is expanding to test a combination of two synthetic antibodies from different companies as a treatment for Covid-19 infections. . . . → Read More: Trial Testing Multi-Company Covid-19 Therapy

Antibodies Prevent Covid-19 Symptoms in Long-Term Care

Mobile lab team

A clinical trial shows long-term care residents and staff receiving a synthetic antibody treatment have a lower risk of getting symptomatic Covid-19 infections. . . . → Read More: Antibodies Prevent Covid-19 Symptoms in Long-Term Care

Tissue Culture: A Novel Propagation Method for Cannabis Industry

One of the more pressing concerns is the development of propagation methods that meet the requirements of mass production. . . . → Read More: Tissue Culture: A Novel Propagation Method for Cannabis Industry

Covid-19 Antibody Developer Raises $483M in IPO

Wall Street sign

A biotechnology company developing therapeutic antibodies for Covid-19 infections is raising $483 million in its initial public offering of common stock. . . . → Read More: Covid-19 Antibody Developer Raises $483M in IPO

Industry, Univ Labs Partner on Cannabinoid Pain Drug

Cannabis plant

A Canadian medical school lab is helping evaluate and develop a pain relief drug made by a company developing therapies from cannabis. . . . → Read More: Industry, Univ Labs Partner on Cannabinoid Pain Drug

Wheat Genome Study IDs Critical Genes, Traits

Curtis Pozniak in wheat field

An international research team identified key features of the complex wheat genome, including genes affecting the grain’s yield, quality, and survival. . . . → Read More: Wheat Genome Study IDs Critical Genes, Traits